查看購物車
  • Simplified Chinese
  • English
  • Japanese
基因轉殖動物的全球市場 - 產業規模，佔有率，趨勢，機會，預測:各產品，各技術，各用途，模式生物，各終端用戶(2017年～2027年)
市場調查報告書
商品編碼
1171633

基因轉殖動物的全球市場 - 產業規模，佔有率，趨勢，機會，預測:各產品，各技術，各用途，模式生物，各終端用戶(2017年～2027年)

Transgenic Animal Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product, By PCR, By Technique, By Application, By Model Organisms, By End User, By Company, and By Region
出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球基因轉殖動物的市場規模在預測期間內的2023年～2027年將達成驚人的成長。

主要因素包括動物源性蛋白質和乳製品消費量的增加，以及研發活動的增加。此外，各種疾病的傳播、技術進步和意識的提高是支持市場增長的其他因素。此外，不斷上漲的醫療費用和《動物福利法》的實施是推動未來市場增長的因素。

本報告提供全球基因轉殖動物市場相關調查分析，提供各市場區隔·各地區的市場規模·佔有率預測，市場動態，企業簡介等系統性資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 全球基因轉殖動物市場上COVID-19的影響

第4章 摘要整理

第5章 VOC (客戶的迴響)

第6章 臨床試驗分析

第7章 全球基因轉殖動物市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各產品(遺傳基因槍，PCR，顯微注射，其他)
    • 各技術(DNA顯微注射，胚胎幹細胞介導的基因轉移，逆轉錄病毒介導的基因轉移，其他)
    • 各用途(重組人蛋白質，單株抗體，異種移植，其他)
    • 模式生物(鼠標，兔子，牛，其他)
    • 各終端用戶(生物科技·製藥公司，學術·研究機關，其他)
    • 各企業(2021年)
    • 各地區
  • 產品市場地圖

第8章 北美的基因轉殖動物市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各產品
    • 各技術
    • 各用途
    • 模式生物
    • 各終端用戶
    • 各國
  • 各國分析
    • 美國
    • 墨西哥
    • 加拿大

第9章 歐洲的基因轉殖動物市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各產品
    • 各技術
    • 各用途
    • 模式生物
    • 各終端用戶
    • 各國
  • 各國分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第10章 亞太地區的基因轉殖動物市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各產品
    • 各技術
    • 各用途
    • 模式生物
    • 各終端用戶
    • 各國
  • 各國分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 越南
    • 印尼
    • 新加坡

第11章 南美的基因轉殖動物市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各產品
    • 各技術
    • 各用途
    • 模式生物
    • 各終端用戶
    • 各國
  • 各國分析
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利

第12章 中東·非洲的基因轉殖動物市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各產品
    • 各技術
    • 各用途
    • 模式生物
    • 各終端用戶
    • 各國
  • 各國分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 埃及
    • 土耳其

第13章 市場動態

  • 促進因素
  • 課題

第14章 市場趨勢與開發

第15章 競爭情形

  • Merck & Co., Inc.
  • C.H. Boehringer Sohn Ko. KG
  • Randox Laboratories Limited
  • Zoetis, Inc.
  • Virbac SA
  • Elanco Animal Health Inc.
  • Biogenesis Bago SA
  • Santa Cruz Biotechnology, Inc
  • Idexx Laboratories, Inc.
  • Innovative Diagnostics(IDVet)

第16章 策略性建議

簡介目錄
Product Code: 12982

The global transgenic animal market is anticipated to observe an impressive growth during the forecast period, 2023-2027. The major factors include increasing consumption of animal-derived protein and dairy products and rise in R&D activities. A transgenic animal is one who's genes are modified to improve both quality and quantity of food demand and also help to understand gene disease. The other factors supporting the market's growth are rise various diseases, advancement in techniques, and growing awareness. Additionally, rising healthcare expenditure and implementation of the animal welfare regulations are driving the growth of the market in upcoming years.

Increasing Consumption of Animal-Derived Protein and Dairy Products

As protein and calcium plays a vital role in nutrition, the consumption of meat and meat products such as dairy products, eggs, beef, and chicken are increasing, which surge the market growth in foreseen years. For instance, genetically modified poultry, such as broilers, have high number of proteins which are easily digestible. Additionally, rapid urbanization and increase in population across the globe are bolstering the market growth. Owing to the increase in animal derived protein supplements and food products, the need for transgenic animals is also rising. Therefore, all these factors are propelling the growth of the transgenic animal market, globally. In 2015, a study by Meat and Livestock in Australia revealed that genetically modified cows can produce more milk and are less susceptible to cattle diseases.

Wide Applications of Transgenic Animals

Transgenic animals have numerous applications in various fields such as agriculture, medical and industrial sectors. They are used to develop new and improved strains of livestock and as model organisms. Development of transgenic farm animals are allowing more flexibility in direct genetic manipulation of livestock. With ever-growing world population and changing climate conditions, such efficient means of increasing food production are needed. In addition, transgenic animals are specifically designed to study the genes in order to develop a cure for the diseases such as Alzheimer's and cancer. For instance, in 2020, Merck Animal Health along with Automazioni VX, Inc. (US) signed an agreement aiming to Innoject Pro, a newly designed subcutaneous chick vaccination technology. The technology will be utilized by coupling with Merck Animal Health's Innovax range of vaccines, which aids for protection against infectious diseases.

Increasing awareness and R&D Initiatives

Various R&D initiatives and awareness programs are initiated by the governments of the respective countries, which is bolstering the growth of the transgenic market. As per a publication by the British Nutrition Foundation 2018, genetically modified cows were anticipated to produce milk without allergy-producing protein, which will make the product apt for lactose-intolerant people. As per the National Institute of Health, in 2017, approximately 8% of the population in the U.K. was suffering from lactose intolerance. Thus, the modifications are likely to provide newer prospects for animal genetics in the upcoming years. Furthermore, the rising initiative to educate on transgenic animal is further anticipated to drive the growth of this market.

Market Segmentation

The global transgenic animal market is segmented into product, PCR, technique, application, model organism, end user and company. Based on product, the market is divided into gene gun, PCR, microinjections, and others. Based on PCR, the market is divided into real-time PCR, digital PCR System, and others. Based on technique, the market is segmented into DNA microinjection, embryonic stem cell-mediated gene transfer, retrovirus-mediated gene transfer, and others. Based on application, the market is segmented into recombinant human proteins, monoclonal antibodies, xenotransplantation, and others. Based on model organisms, the market is segmented into mice, rabbit, cow, and others. Based on end user, the market is segmented into biotechnology & pharmaceutical companies, academic & research organizations, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising animal-based protein food and growing occurrence of diseases in the country.

Market Players Merck & Co., Inc., C.H. Boehringer Sohn Ko. KG, Randox Laboratories Limited, Zoetis, Inc., Virbac SA, Elanco Animal Health Inc., Biogenesis Bago SA, Santa Cruz Biotechnology, Inc, Idexx Laboratories, Inc., and Innovative Diagnostics (IDVet) are some of the leading companies operating in the market.

Report Scope

In this report, global transgenic animal market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Transgenic Animal Market, By Product:

  • Gene Gun
  • PCR
    • Real-Time PCR
    • Digital PCR Systems
    • Others
  • Microinjections
  • Others

Transgenic Animal Market, By Technique:

  • DNA Microinjection
  • Embryonic Stem Cell-Mediated Gene Transfer
  • Retrovirus-Mediated Gene Transfer
  • Others

Transgenic Animal Market, By Application:

  • Recombinant Human Proteins
  • Monoclonal Antibodies
  • Xenotransplantation
  • Others

Transgenic Animal Market, By Model Organisms:

  • Mice
  • Rabbit
  • Cow
  • Others

Transgenic Animal Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Organizations
  • Others

Transgenic Animal Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Transgenic Animal Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Transgenic Animal Market

4. Executive Summary

5. Voice of Customer

6. Clinical Trial Analysis

7. Global Transgenic Animal Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
      • 7.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
    • 7.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
    • 7.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
    • 7.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
    • 7.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
    • 7.2.6. By Company (2021)
    • 7.2.7. By Region
  • 7.3. Product Market Map

8. North America Transgenic Animal Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
      • 8.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
    • 8.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
    • 8.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
    • 8.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
    • 8.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
    • 8.2.6. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Transgenic Animal Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By Model Organisms
        • 8.3.1.2.5. By End User
    • 8.3.2. Mexico Transgenic Animal Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By Model Organisms
        • 8.3.2.2.5. By End User
    • 8.3.3. Canada Transgenic Animal Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By Model Organisms
        • 8.3.3.2.5. By End User

9. Europe Transgenic Animal Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
      • 9.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
    • 9.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
    • 9.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
    • 9.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
    • 9.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
    • 9.2.6. By Country
  • 9.3. Europe: Country Analysis
    • 9.3.1. France Transgenic Animal Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By Model Organisms
        • 9.3.1.2.5. By End User
    • 9.3.2. Germany Transgenic Animal Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By Model Organisms
        • 9.3.2.2.5. By End User
    • 9.3.3. United Kingdom Transgenic Animal Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By Model Organisms
        • 9.3.3.2.5. By End User
    • 9.3.4. Italy Transgenic Animal Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Technique
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By Model Organisms
        • 9.3.4.2.5. By End User
    • 9.3.5. Spain Transgenic Animal Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product
        • 9.3.5.2.2. By Technique
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By Model Organisms
        • 9.3.5.2.5. By End User

10. Asia-Pacific Transgenic Animal Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
      • 10.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
    • 10.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
    • 10.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
    • 10.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
    • 10.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
    • 10.2.6. By Country
  • 10.3. Asia-Pacific: Country Analysis
    • 10.3.1. China Transgenic Animal Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By Model Organisms
        • 10.3.1.2.5. By End User
    • 10.3.2. India Transgenic Animal Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By Model Organisms
        • 10.3.2.2.5. By End User
    • 10.3.3. Japan Transgenic Animal Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By Model Organisms
        • 10.3.3.2.5. By End User
    • 10.3.4. South Korea Transgenic Animal Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Technique
        • 10.3.4.2.3. By Application
        • 10.3.4.2.4. By Model Organisms
        • 10.3.4.2.5. By End User
    • 10.3.5. Australia Transgenic Animal Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Product
        • 10.3.5.2.2. By Technique
        • 10.3.5.2.3. By Application
        • 10.3.5.2.4. By Model Organisms
        • 10.3.5.2.5. By End User
    • 10.3.6. Vietnam Transgenic Animal Market Outlook
      • 10.3.6.1. Market Size & Forecast
        • 10.3.6.1.1. By Value
      • 10.3.6.2. Market Share & Forecast
        • 10.3.6.2.1. By Product
        • 10.3.6.2.2. By Technique
        • 10.3.6.2.3. By Application
        • 10.3.6.2.4. By Model Organisms
        • 10.3.6.2.5. By End User
    • 10.3.7. Indonesia Transgenic Animal Market Outlook
      • 10.3.7.1. Market Size & Forecast
        • 10.3.7.1.1. By Value
      • 10.3.7.2. Market Share & Forecast
        • 10.3.7.2.1. By Product
        • 10.3.7.2.2. By Technique
        • 10.3.7.2.3. By Application
        • 10.3.7.2.4. By Model Organisms
        • 10.3.7.2.5. By End User
    • 10.3.8. Singapore Transgenic Animal Market Outlook
      • 10.3.8.1. Market Size & Forecast
        • 10.3.8.1.1. By Value
      • 10.3.8.2. Market Share & Forecast
        • 10.3.8.2.1. By Product
        • 10.3.8.2.2. By Technique
        • 10.3.8.2.3. By Application
        • 10.3.8.2.4. By Model Organisms
        • 10.3.8.2.5. By End User

11. South America Transgenic Animal Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
      • 11.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
    • 11.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
    • 11.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
    • 11.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
    • 11.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
    • 11.2.6. By Country
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Transgenic Animal Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Technique
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By Model Organisms
        • 11.3.1.2.5. By End User
    • 11.3.2. Argentina Transgenic Animal Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Technique
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By Model Organisms
        • 11.3.2.2.5. By End User
    • 11.3.3. Colombia Transgenic Animal Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Technique
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By Model Organisms
        • 11.3.3.2.5. By End User
    • 11.3.4. Chile Transgenic Animal Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product
        • 11.3.4.2.2. By Technique
        • 11.3.4.2.3. By Application
        • 11.3.4.2.4. By Model Organisms
        • 11.3.4.2.5. By End User

12. Middle East and Africa Transgenic Animal Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
      • 12.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
    • 12.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
    • 12.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
    • 12.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
    • 12.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
    • 12.2.6. By Country
  • 12.3. MEA: Country Analysis
    • 12.3.1. South Africa Transgenic Animal Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Product
        • 12.3.1.2.2. By Technique
        • 12.3.1.2.3. By Application
        • 12.3.1.2.4. By Model Organisms
        • 12.3.1.2.5. By End User
    • 12.3.2. Saudi Arabia Transgenic Animal Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Product
        • 12.3.2.2.2. By Technique
        • 12.3.2.2.3. By Application
        • 12.3.2.2.4. By Model Organisms
        • 12.3.2.2.5. By End User
    • 12.3.3. UAE Transgenic Animal Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Product
        • 12.3.3.2.2. By Technique
        • 12.3.3.2.3. By Application
        • 12.3.3.2.4. By Model Organisms
        • 12.3.3.2.5. By End User
    • 12.3.4. Egypt Transgenic Animal Market Outlook
      • 12.3.4.1. Market Size & Forecast
        • 12.3.4.1.1. By Value
      • 12.3.4.2. Market Share & Forecast
        • 12.3.4.2.1. By Product
        • 12.3.4.2.2. By Technique
        • 12.3.4.2.3. By Application
        • 12.3.4.2.4. By Model Organisms
        • 12.3.4.2.5. By End User
    • 12.3.5. Turkey Transgenic Animal Market Outlook
      • 12.3.5.1. Market Size & Forecast
        • 12.3.5.1.1. By Value
      • 12.3.5.2. Market Share & Forecast
        • 12.3.5.2.1. By Product
        • 12.3.5.2.2. By Technique
        • 12.3.5.2.3. By Application
        • 12.3.5.2.4. By Model Organisms
        • 12.3.5.2.5. By End User

13. Market Dynamics

  • 13.1. Drivers
  • 13.2. Challenges

14. Market Trends & Developments

15. Competitive Landscape (inclusive of SWOT Analysis)

  • 15.1. Merck & Co., Inc.
  • 15.2. C.H. Boehringer Sohn Ko. KG
  • 15.3. Randox Laboratories Limited
  • 15.4. Zoetis, Inc.
  • 15.5. Virbac SA
  • 15.6. Elanco Animal Health Inc.
  • 15.7. Biogenesis Bago SA
  • 15.8. Santa Cruz Biotechnology, Inc
  • 15.9. Idexx Laboratories, Inc.
  • 15.10. Innovative Diagnostics (IDVet)

16. Strategic Recommendations